Evolent Health Stock Plummets to New 52-Week Low of $6.53

Evolent Health, Inc. has reached a new 52-week low, trading at USD 6.53 as of October 31, 2025. This marks a significant decline for the small-cap company, which has seen its stock price plummet by 71.88% over the past year, contrasting sharply with the S&P 500's performance of 19.89% during the same period.
The company's financial metrics reflect ongoing difficulties, including a return on equity of -10.28% and a return on capital employed averaging just 0.44%. Evolent Health has reported negative results for three consecutive quarters, with pre-tax profits falling by 355.12% and net profits declining by 311.27%. Additionally, the operating cash flow has reached a low of USD -33.32 million.

With a market capitalization of USD 1,151 million, Evolent Health operates within the miscellaneous industry and currently offers no dividend yield. The stock's price-to-book ratio stands at 1.28, indicating potential concerns regarding its valuation relative to its assets. Overall, the recent price movement underscores the company's ongoing challenges in the market.